Enliven Therapeutics, Inc. (ELVN)
(Delayed Data from NSDQ)
$18.84 USD
-0.38 (-1.98%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $18.89 +0.05 (0.27%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Enliven Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ELVN 18.84 -0.38(-1.98%)
Will ELVN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELVN
Can Enliven Therapeutics, Inc. (ELVN) Climb 75.66% to Reach the Level Wall Street Analysts Expect?
Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why
ELVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Momentum in Enliven Therapeutics, Inc. (ELVN) Should Keep going
Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High?
Wall Street Analysts Think Enliven Therapeutics, Inc. (ELVN) Could Surge 43.04%: Read This Before Placing a Bet
Other News for ELVN
BlackRock, Inc. Reduces Stake in Enliven Therapeutics Inc.
Enliven Therapeutics Inc Breaks Above 200-Day Moving Average - Bullish for ELVN
COMMODORE CAPITAL LP Acquires 1,175,000 Shares in Cidara Therapeutics Inc
Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday
Enliven Therapeutics (ELVN) Receives Raised Price Target from HC Wainwright & Co. ...